coronavirus
EU taxpayers should know precisely how their money is used for vaccine development

In the European Parliament’s committee on budgets, members heard Ms Sandra Gallina, director for health and food safety (DG SANTE) at the European Commission on the clarity needed in relation to the financing of its COVID-19 strategy.
Unfortunately, S&D Group MEPs are not satisfied with the answers provided and are still requesting further detail, in whatever form (Court of Auditors report, hearings with CEOs of pharmaceutical companies or commissioners, quicker and wider publication of the Anticipatory Purchase Agreements between the Commission and pharmaceutical companies).
Eider Gardiazábal Rubial MEP, S&D spokeswoman on budget, said: “Over the past few months, we have been asked to refill the EU budget twice, up to €3 billion in total, largely to finance the accelerated vaccine research investments of pharmaceutical companies. So far, we still do not know clearly how much went to which company. On top of this, member states claim they had to complement these amounts as that money has been used up, and again, we do not know how much each. I do not want to believe that pharma companies are rushing for profit in these times. Solidarity in the face of a common threat is what guides our European response to COVID-19.
“Parliament lived up to its responsibilities in the urgent context we were facing. Now citizens want to know how it was done and they have that right. The S&Ds have taken on this cause, and will not drop it until these questions are answered in detail.”
Share this article:
EU Reporter publishes articles from a variety of outside sources which express a wide range of viewpoints. The positions taken in these articles are not necessarily those of EU Reporter. Please see EU Reporter’s full Terms and Conditions of publication for more information EU Reporter embraces artificial intelligence as a tool to enhance journalistic quality, efficiency, and accessibility, while maintaining strict human editorial oversight, ethical standards, and transparency in all AI-assisted content. Please see EU Reporter’s full A.I. Policy for more information.

-
Anti-semitism4 days ago
Antisemitic incitement: Posters with names and photos of Jewish personalities displayed in Brussels with the accusation: ‘He/She lobbies for genocide.’
-
Africa4 days ago
AfDB: Challenges in a historic context for Sidi Ould Tah
-
Artificial intelligence3 days ago
Generative AI set to transform EU economy but requires further policy action
-
Decarbonization4 days ago
Commission assesses nuclear investment needs by 2050 in view of decarbonization and competitiveness goals